In addition, the GSEA results showed that the genetic changes in the high-risk endometrial cancer patient group were related to the B cell receptor, insulin, JAK-STAT, MAPK and NOD-like receptor signalling pathways. This evidence concerns the gene INS and endometrial cancer.